Proximity-Dependent Biotinylation to Elucidate the Interactome of TNK2 Nonreceptor Tyrosine Kinase

Raiha Tahir1,2,3, Anil K Madugundu4,5,6,7,8, Savita Udainiya4,7,8

  • 1Biochemistry, Cellular and Molecular Biology Graduate Program, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, United States.

Insights

This study maps protein interactions of TNK2, a kinase implicated in cancer. Using advanced BioID and BioSITe methods, researchers identified known and novel TNK2 partners, including CLINT1, offering new insights into cancer signaling pathways.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Cancer Research

Background:

  • Nonreceptor tyrosine kinases (NRTKs) are crucial signaling molecules.
  • TNK2, an NRTK, is linked to cancer development and progression.
  • Understanding TNK2's downstream effectors is vital for cancer therapy.

Purpose of the Study:

  • To comprehensively map the TNK2 interactome using proximity-dependent biotinylation.
  • To identify novel protein interactors and substrates of TNK2.
  • To validate the interaction between TNK2 and the novel partner CLINT1.

Main Methods:

  • Utilized BioID (proximity-dependent biotinylation) coupled with BioSITe (biotinylation site identification technology).
  • Employed stable isotope labeling with amino acids in cell culture (SILAC) for quantitative analysis.
  • Performed co-immunoprecipitation and immunofluorescence assays for validation.

Main Results:

  • Identified site-level biotinylation of known TNK2 binders/substrates (NCK1, NCK2, CTTN, STAT3).
  • Discovered several novel TNK2 interacting partners, including CLINT1.
  • Validated the TNK2-CLINT1 interaction using co-immunoprecipitation and immunofluorescence.

Conclusions:

  • The BioSITe method coupled with BioID is a powerful tool for quantitative interactome mapping.
  • Identified novel TNK2 interactors like CLINT1 warrant further investigation for their role in cancer.
  • This study provides a foundation for understanding TNK2-mediated signaling in cancer.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.3K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.2K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.9K